AVR · Anteris Technologies Global Corp.

Summary

Anteris Technologies Global Corp. furnished its audited FY2025 financial results via Exhibits 99.1 and 99.2, reporting revenues of US$1.913 million (down 29% from US$2.703 million in 2024) and a net loss attributable to members of US$94.144 million (up 23% from US$76.291 million). The filing highlights clinical progress on DurAVR THV including PARADIGM Trial initiation.

Key takeaways

• Event Type: FY2025 Earnings Release (Items: 2.02)